Long-term outcome of patients with atrioventricular node reentrant tachycardia

International Journal of Cardiology

Volumn 115, Issue 3, 2007, Pages 350-353

  D'Este, Daniele ^a   Zoppo, Franco ^a   Bertaglia, Emanuele ^a   Zerbo, Francesca ^a   Picciolo, Amedeo ^a   Scarabeo, Virginia ^a   Pascotto, Andrea ^a   Pascotto, Pietro ^a  

^a Department of Cardiology   (Italy)

Author keywords

Atrioventricular node reentrant tachycardia; Outcome

Indexed keywords

ANTIARRHYTHMIC AGENT; ATENOLOL; DILTIAZEM; FLECAINIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

ADOLESCENT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SYMPTOM; TACHYCARDIA;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; COHORT STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846701296     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.04.035     Document Type: Article

References (19)

1. Akhtar M., Jazayeri M., Sra J., Blank K., Desphande S., and Dhala A. Atrioventricular nodal reentry: clinical, electrophysiological and therapeutic considerations. Circulation 88 (1993) 282-295
2. Campbell R.W. What happens to people with "supra" ventricular tachycardia?. Eur Heart J 15 suppl A (1994) 27-30
3. Gallagher J.J., Smith W.N., Kassel J., et al. Use of the esophageal lead in the diagnosis of mechanism of reciprocating tachycardia. PACE 3 (1980) 440-448
4. Calkins H., Sousa J., El-Atassi R., et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiological test. New England J Med 324 (1991) 1612-1618
5. Cheng C.H.F., Sanders G.D., Hlatky M.A., et al. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. Ann Intern Med 133 (2000) 864-876
6. Anderson R.H., Becker A.E., Brechenmacher C., Davies M.J., and Rossi L. The human atrioventricular junctional area. A morphological study of the A-V node and bundle. Eur J Cardiol 3 (1975) 11-25
7. Goyal R., Zivin A., Souza J., et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J 132 (1996) 765-767
8. Rodriguez L., De Chillou C., Schlapfer J., et al. Age at onset and gender of patients with different types of supraventricular tachycardias. Am J Cardiol 70 (1992) 1213-1215
9. D'Este D., Bertaglia E., Zanocco A., Reimers B., and Pascotto P. Electrophysiological properties of the atrioventricular node and ageing: evidence of a lower incidence of dual nodal pathways in the elderly. Europace 3 (2001) 216-220
10. Chen S., Chiang C., Tai C., et al. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia. Circulation 93 (1996) 2023-2032
11. Poutiainen A.M., Koistinen M.J., Airaksinen K.E.J., et al. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J 20 (1999) 694-700
12. Krahn A.D., Manfreda J., and Tate R.B. The natural history of electrocardiographic pre-excitation in men: the Manitoba follow-up study. Ann Intern Med 116 (1992) 456-460
13. Klein J., Yee R., and Sharma A. Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med 320 (1989) 1229-1233
14. Ikeda T., Sugi K., Enjoji Y., et al. Cost effectiveness of radiofrequency catheter versus medical treatment for paroxysmal supraventricular tachycardia in Japan. J Cardiol 24 (1994) 461-468
15. Bathina M.N., Mickelsen S., Brooks, Jaramillo J., Hepton T., and Kusumoto F.M. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol 82 (1998) 589-593
16. Alboni P., Tomasi C., Menozzi C., et al. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol 37 (2001) 548-553
17. Hlatky M.A., and Vaughn W.K. Quality of life in patients with supraventricular arrhythmia. Circulation 94 (1996) 1491-1493
18. Goldberg A.S., Bathina M.N., Mickelsen S., Nawman R., West G., and Kusumoto F.M. Long-term outcomes on quality of life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol 89 (2002) 1120-1123
19. Calkins H., Yong P., Miller J.M., et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction. Final results of a prospective, multicenter clinical trial. Circulation 99 (1999) 262-270